Table of Contents Chapter 1 Hepatocellular Carcinoma Drug Market Overview 1.1 Hepatocellular Carcinoma Drug Definition 1.2 Global Hepatocellular Carcinoma Drug Market Size Status and Outlook (2013-2028) 1.3 Global Hepatocellular Carcinoma Drug Market Size Comparison by Region (2013-2028) 1.4 Global Hepatocellular Carcinoma Drug Market Size Comparison by Type (2013-2028) 1.5 Global Hepatocellular Carcinoma Drug Market Size Comparison by Application (2013-2028) 1.6 Global Hepatocellular Carcinoma Drug Market Size Comparison by Sales Channel (2013-2028) 1.7 Hepatocellular Carcinoma Drug Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Hepatocellular Carcinoma Drug Market Segment Analysis by Player 2.1 Global Hepatocellular Carcinoma Drug Sales and Market Share by Player (2016-2018) 2.2 Global Hepatocellular Carcinoma Drug Revenue and Market Share by Player (2016-2018) 2.3 Global Hepatocellular Carcinoma Drug Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Hepatocellular Carcinoma Drug Market Segment Analysis by Type 3.1 Global Hepatocellular Carcinoma Drug Market by Type 3.1.1 Chemotherapy 3.1.2 Brachytherapy 3.1.3 Ablation Therapy 3.2 Global Hepatocellular Carcinoma Drug Sales and Market Share by Type (2013-2018) 3.3 Global Hepatocellular Carcinoma Drug Revenue and Market Share by Type (2013-2018) 3.4 Global Hepatocellular Carcinoma Drug Average Price by Type (2013-2018) 3.5 Leading Players of Hepatocellular Carcinoma Drug by Type in 2018 3.6 Conclusion of Segment by Type Chapter 4 Hepatocellular Carcinoma Drug Market Segment Analysis by Application 4.1 Global Hepatocellular Carcinoma Drug Market by Application 4.1.1 Surgical Resection 4.1.2 Liver Transplantation 4.1.3 Ablation 4.2 Global Hepatocellular Carcinoma Drug Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Hepatocellular Carcinoma Drug by Application in 2018 4.4 Conclusion of Segment by Application Chapter 5 Hepatocellular Carcinoma Drug Market Segment Analysis by Sales Channel 5.1 Global Hepatocellular Carcinoma Drug Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Hepatocellular Carcinoma Drug Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Hepatocellular Carcinoma Drug by Sales Channel in 2018 5.4 Conclusion of Segment by Sales Channel Chapter 6 Hepatocellular Carcinoma Drug Market Segment Analysis by Region 6.1 Global Hepatocellular Carcinoma Drug Market Size and CAGR by Region (2013-2028) 6.2 Global Hepatocellular Carcinoma Drug Sales and Market Share by Region (2013-2018) 6.3 Global Hepatocellular Carcinoma Drug Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Hepatocellular Carcinoma Drug Market Share by Type 6.4.3 North America Hepatocellular Carcinoma Drug Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Hepatocellular Carcinoma Drug Market Share by Type 6.5.3 Europe Hepatocellular Carcinoma Drug Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Hepatocellular Carcinoma Drug Market Share by Type 6.6.3 Asia-Pacific Hepatocellular Carcinoma Drug Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Hepatocellular Carcinoma Drug Market Share by Type 6.7.3 South America Hepatocellular Carcinoma Drug Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Hepatocellular Carcinoma Drug Market Share by Type 6.8.3 Middle East & Africa Hepatocellular Carcinoma Drug Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Hepatocellular Carcinoma Drug Players 7.1 Johnson & Johnson 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Gilead Sciences 7.3 Pacira 7.4 Sun Pharmaceutical 7.5 Luye Pharma 7.6 Sigma-Tau Group 7.7 Fudan-Zhangjiang 7.8 Teva Pharmaceutical 7.9 CSPC 7.10 Novartis 7.11 Kingond Pharm Chapter 8 Upstream and Downstream Analysis of Hepatocellular Carcinoma Drug 8.1 Industrial Chain of Hepatocellular Carcinoma Drug 8.2 Upstream of Hepatocellular Carcinoma Drug 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Hepatocellular Carcinoma Drug 8.3.1 Leading Distributors/Dealers of Hepatocellular Carcinoma Drug 8.3.2 Leading Consumers of Hepatocellular Carcinoma Drug Chapter 9 Development Trend of Hepatocellular Carcinoma Drug (2019-2028) 9.1 Global Hepatocellular Carcinoma Drug Market Size (Sales and Revenue) Forecast (2019-2028) 9.2 Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Region (2019-2028) 9.3 Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Type (2019-2028) 9.4 Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Application (2019-2028) 9.5 Global Hepatocellular Carcinoma Drug Market Size Forecast by Sales Channel (2019-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Hepatocellular Carcinoma Drug Example Figure Global Hepatocellular Carcinoma Drug Revenue (Million $) Status and Outlook (2013-2028) Figure Global Hepatocellular Carcinoma Drug Revenue (Million $) Comparison by Region (2013-2028) Figure Global Hepatocellular Carcinoma Drug Sales Comparison by Type (2013-2028) Figure Global Hepatocellular Carcinoma Drug Sales Comparison by Application (2013-2028) Figure Global Hepatocellular Carcinoma Drug Sales Comparison by Sales Channel (2013-2028) Table Global Hepatocellular Carcinoma Drug Sales by Player (2016-2018) Table Global Hepatocellular Carcinoma Drug Sales Market Share by Player (2016-2018) Figure Global Hepatocellular Carcinoma Drug Sales Market Share by Player in 2018 Table Global Hepatocellular Carcinoma Drug Revenue (Million $) by Player (2016-2018) Table Global Hepatocellular Carcinoma Drug Revenue Market Share by Player (2016-2018) Figure Global Hepatocellular Carcinoma Drug Revenue Market Share by Player in 2018 Table Global Hepatocellular Carcinoma Drug Average Price by Player (2016-2018) Figure Global Hepatocellular Carcinoma Drug Average Price by Player in 2018 Figure Global Hepatocellular Carcinoma Drug Players Competition Situation – Top 5 Players’ Revenue Market Share in 2016 Figure Global Hepatocellular Carcinoma Drug Players Competition Trends – Top 5 Players’ Revenue Market Share in 2018 Figure Example of Chemotherapy Figure Global Chemotherapy Sales and Growth Rate (2013-2018) Figure Example of Brachytherapy Figure Global Brachytherapy Sales and Growth Rate (2013-2018) Figure Example of Ablation Therapy Figure Global Ablation Therapy Sales and Growth Rate (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales by Type (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales Market Share by Type (2013-2018) Figure Global Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Table Global Hepatocellular Carcinoma Drug Revenue (Million $) by Type (2013-2018) Table Global Hepatocellular Carcinoma Drug Revenue Market Share by Type (2013-2018) Figure Global Hepatocellular Carcinoma Drug Revenue Market Share by Type in 2018 Table Global Hepatocellular Carcinoma Drug Average Price by Type (2013-2018) Figure Global Hepatocellular Carcinoma Drug Average Price by Type in 2018 Table Leading Players of Hepatocellular Carcinoma Drug by Type in 2018 Figure Example of Surgical Resection Figure Global Hepatocellular Carcinoma Drug for Surgical Resection Sales and Growth Rate (2013-2018) Figure Example of Liver Transplantation Figure Global Hepatocellular Carcinoma Drug for Liver Transplantation Sales and Growth Rate (2013-2018) Figure Example of Ablation Figure Global Hepatocellular Carcinoma Drug for Ablation Sales and Growth Rate (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales by Application (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales Market Share by Application (2013-2018) Figure Global Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Table Leading Consumers of Hepatocellular Carcinoma Drug by Application in 2018 Figure Example of Direct Channel Figure Global Hepatocellular Carcinoma Drug for Direct Channel Sales and Growth Rate (2013-2018) Figure Example of Distribution Channel Figure Global Hepatocellular Carcinoma Drug for Distribution Channel Sales and Growth Rate (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales by Sales Channel (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales Market Share by Sales Channel (2013-2018) Figure Global Hepatocellular Carcinoma Drug Sales Market Share by Sales Channel in 2018 Table Leading Distributors/Dealers of Hepatocellular Carcinoma Drug by Sales Channel in 2018 Table Global Hepatocellular Carcinoma Drug Market Size and CAGR by Region (2013-2028) Table Global Hepatocellular Carcinoma Drug Sales by Region (2013-2018) Table Global Hepatocellular Carcinoma Drug Sales Market Share by Region (2013-2018) Figure Global Hepatocellular Carcinoma Drug Sales Market Share by Region in 2018 Table Global Hepatocellular Carcinoma Drug Revenue (Million $) by Region (2013-2018) Table Global Hepatocellular Carcinoma Drug Revenue Market Share by Region (2013-2018) Figure Global Hepatocellular Carcinoma Drug Revenue Market Share by Region in 2018 Table North America Hepatocellular Carcinoma Drug Sales by Country (2013-2018) Figure North America Hepatocellular Carcinoma Drug Sales Market Share by Country (2013-2018) Table North America Hepatocellular Carcinoma Drug Revenue by Country (2013-2018) Figure North America Hepatocellular Carcinoma Drug Revenue Market Share by Country (2013-2018) Figure North America Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Figure North America Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Figure United States Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure United States Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Canada Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Canada Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Mexico Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Mexico Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Table Europe Hepatocellular Carcinoma Drug Sales by Country (2013-2018) Figure Europe Hepatocellular Carcinoma Drug Sales Market Share by Country (2013-2018) Table Europe Hepatocellular Carcinoma Drug Revenue by Country (2013-2018) Figure Europe Hepatocellular Carcinoma Drug Revenue Market Share by Country (2013-2018) Figure Europe Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Figure Europe Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Figure Germany Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Germany Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure UK Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure UK Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure France Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure France Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Italy Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Italy Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Russia Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Russia Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Spain Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Spain Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Table Asia-Pacific Hepatocellular Carcinoma Drug Sales by Country (2013-2018) Figure Asia-Pacific Hepatocellular Carcinoma Drug Sales Market Share by Country (2013-2018) Table Asia-Pacific Hepatocellular Carcinoma Drug Revenue by Country (2013-2018) Figure Asia-Pacific Hepatocellular Carcinoma Drug Revenue Market Share by Country (2013-2018) Figure Asia-Pacific Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Figure Asia-Pacific Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Figure China Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure China Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Japan Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Japan Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Korea Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Korea Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure India Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure India Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Southeast Asia Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Southeast Asia Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Australia Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Australia Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Table South America Hepatocellular Carcinoma Drug Sales by Country (2013-2018) Figure South America Hepatocellular Carcinoma Drug Sales Market Share by Country (2013-2018) Table South America Hepatocellular Carcinoma Drug Revenue by Country (2013-2018) Figure South America Hepatocellular Carcinoma Drug Revenue Market Share by Country (2013-2018) Figure South America Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Figure South America Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Figure Brazil Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Brazil Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Argentina Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Argentina Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Colombia Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Colombia Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Chile Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Chile Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Table Middle East & Africa Hepatocellular Carcinoma Drug Sales by Country (2013-2018) Figure Middle East & Africa Hepatocellular Carcinoma Drug Sales Market Share by Country (2013-2018) Table Middle East & Africa Hepatocellular Carcinoma Drug Revenue by Country (2013-2018) Figure Middle East & Africa Hepatocellular Carcinoma Drug Revenue Market Share by Country (2013-2018) Figure Middle East & Africa Hepatocellular Carcinoma Drug Sales Market Share by Type in 2018 Figure Middle East & Africa Hepatocellular Carcinoma Drug Sales Market Share by Application in 2018 Figure Egypt Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Egypt Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Saudi Arabia Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Saudi Arabia Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure South Africa Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure South Africa Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Figure Nigeria Hepatocellular Carcinoma Drug Sales and Growth Rate (2013-2018) Figure Nigeria Hepatocellular Carcinoma Drug Revenue (Million $) and Growth Rate (2013-2018) Table Company Snapshot of Johnson & Johnson Table Hepatocellular Carcinoma Drug Introduction of Johnson & Johnson Table Hepatocellular Carcinoma Drug Sales, Price, Revenue, Gross Margin and Market Share of Johnson & Johnson (2016-2018) Table Industrial Chain of Hepatocellular Carcinoma Drug Table Manufacturing Cost Structure of Hepatocellular Carcinoma Drug Table General Manufacturing Process of Hepatocellular Carcinoma Drug Table Leading Distributors/Dealers of Hepatocellular Carcinoma Drug Table Leading Consumers of Hepatocellular Carcinoma Drug Figure Global Hepatocellular Carcinoma Drug Sales and Growth Rate Forecast (2019-2028) Figure Global Hepatocellular Carcinoma Drug Revenue and Growth Rate Forecast (2019-2028) Table Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Region (2019-2028) Table Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Type (2019-2028) Table Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Application (2019-2028) Table Global Hepatocellular Carcinoma Drug Market Size and CAGR Forecast by Sales Channel (2019-2028)

Johnson & Johnson Gilead Sciences Pacira Sun Pharmaceutical Luye Pharma Sigma-Tau Group Fudan-Zhangjiang Teva Pharmaceutical CSPC Novartis Kingond Pharm